These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Focus on vitamin D therapy in chronic kidney disease. Tentori F J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134 [No Abstract] [Full Text] [Related]
23. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease. Bencova V; Maris K; Spustova V; Gazovic V; Straussova Z; Cernohorska B; Nemethova D Bratisl Lek Listy; 2014; 115(7):439-41. PubMed ID: 25077368 [TBL] [Abstract][Full Text] [Related]
24. Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease. Žamboch K; Krejčí K; Škarda J; Tichý M; Überall I; Skýpalová P; Langová K; Stejskal D; Švesták M; Zahálková J; Ščudla V; Zadražil J Int Urol Nephrol; 2015 Jul; 47(7):1195-201. PubMed ID: 25931273 [TBL] [Abstract][Full Text] [Related]
25. Fibroblast Growth Factor 23 and the Last Mile. Gutiérrez OM Clin J Am Soc Nephrol; 2020 Sep; 15(9):1355-1357. PubMed ID: 32276945 [No Abstract] [Full Text] [Related]
26. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience. Liangos O; Kirchhoff S; Buchholz J; Ketteler M Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519 [TBL] [Abstract][Full Text] [Related]
30. When, how, and why a bone biopsy should be performed in patients with chronic kidney disease. Torres PU; Bover J; Mazzaferro S; de Vernejoul MC; Cohen-Solal M Semin Nephrol; 2014 Nov; 34(6):612-25. PubMed ID: 25498380 [TBL] [Abstract][Full Text] [Related]
31. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703 [TBL] [Abstract][Full Text] [Related]
33. Commentary. Cantor T Clin Chem; 2009 Sep; 55(9):1740. PubMed ID: 19717661 [No Abstract] [Full Text] [Related]
34. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment. Lye WC; Lee EJ Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414 [TBL] [Abstract][Full Text] [Related]
35. GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease. Canney M; Djurdjev O; Tang M; Zierold C; Blocki F; Wolf M; Levin A Am J Nephrol; 2019; 50(2):105-114. PubMed ID: 31238301 [TBL] [Abstract][Full Text] [Related]
36. Update on the role of bone biopsy in the management of patients with CKD-MBD. Evenepoel P; Behets GJS; Laurent MR; D'Haese PC J Nephrol; 2017 Oct; 30(5):645-652. PubMed ID: 28831679 [TBL] [Abstract][Full Text] [Related]
37. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Meany DL; Jan de Beur SM; Bill MJ; Sokoll LJ Clin Chem; 2009 Sep; 55(9):1737-9. PubMed ID: 19717659 [No Abstract] [Full Text] [Related]
38. Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease. Ursem SR; Heijboer AC; D'Haese PC; Behets GJ; Cavalier E; Vervloet MG; Evenepoel P Kidney Int; 2021 May; 99(5):1173-1178. PubMed ID: 33422551 [TBL] [Abstract][Full Text] [Related]
39. [Renal osteodystrophy]. Schober HC Z Urol Nephrol; 1986 Oct; 79(10):595-602. PubMed ID: 3811647 [No Abstract] [Full Text] [Related]
40. Osteoporosis and adynamic bone in chronic kidney disease. Cannata-Andía JB; Rodriguez García M; Gómez Alonso C J Nephrol; 2013; 26(1):73-80. PubMed ID: 23023723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]